Torii Pharmaceutical Co., Ltd. (TYO:4551)
4,395.00
-55.00 (-1.24%)
Mar 10, 2025, 3:30 PM JST
Torii Pharmaceutical Revenue
In the year 2024, Torii Pharmaceutical had annual revenue of 60.43B JPY with 10.59% growth. Torii Pharmaceutical had revenue of 17.09B in the quarter ending December 31, 2024, with 10.23% growth.
Revenue
60.43B
Revenue Growth
+10.59%
P/S Ratio
2.09
Revenue / Employee
103.65M
Employees
583
Market Cap
126.19B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 60.43B | 5.79B | 10.59% |
Dec 31, 2023 | 54.64B | 5.74B | 11.74% |
Dec 31, 2022 | 48.90B | 1.91B | 4.06% |
Dec 31, 2021 | 46.99B | 5.29B | 12.68% |
Dec 31, 2020 | 41.70B | -1.30B | -3.02% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,170.61B |
Takeda Pharmaceutical Company | 4,579.02B |
Daiichi Sankyo Company | 1,795.99B |
HOYA Corporation | 837.44B |
Terumo | 1,011.15B |
Otsuka Holdings | 2,329.86B |
Astellas Pharma | 1,867.63B |
Olympus | 993.33B |